Advertisement

Browse Subject Areas

?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

Myeloma cells

Serum proteomic profiling reveals MTA2 and AGO2 as potential prognostic biomarkers associated with disease activity and adverse outcomes in multiple myeloma

Dollapak Apipongrat, Sittiruk Roytrakul, [ ... ], Oytip Nathalang

Relevance of diffusion-weighted imaging with background body signal suppression for staging, prognosis, morphology, treatment response, and apparent diffusion coefficient in plasma-cell neoplasms: A single-center, retrospective study

Akiko Yamada, Yoichi Araki, [ ... ], Akihiko Gotoh

CRISPR/Cas9 mediated knock-out of VPREB1 gene induces a cytotoxic effect in myeloma cells

Mai Khaled, Amr S. Moustafa, [ ... ], Eman M. El_Salahy

APOBEC3B reporter myeloma cell lines identify DNA damage response pathways leading to APOBEC3B expression

Hiroyuki Yamazaki, Kotaro Shirakawa, [ ... ], Akifumi Takaori-Kondo

ARQ-197, a small-molecule inhibitor of c-Met, reduces tumour burden and prevents myeloma-induced bone disease in vivo

Darren L. Lath, Clive H. Buckle, [ ... ], Andrew D. Chantry

TGF-β contamination of purified recombinant GDF15

Oddrun Elise Olsen, Anette Skjærvik, [ ... ], Toril Holien

The KISS1 Receptor as an In Vivo Microenvironment Imaging Biomarker of Multiple Myeloma Bone Disease

Julia Dotterweich, Robert J. Tower, [ ... ], Franz Jakob

Deletion of Chromosomal Region 8p21 Confers Resistance to Bortezomib and Is Associated with Upregulated Decoy TRAIL Receptor Expression in Patients with Multiple Myeloma

Adil Doganay Duru, Tolga Sutlu, [ ... ], Evren Alici

Lipopolysaccharide-Induced CXCL10 mRNA Level and Six Stimulant-mRNA Combinations in Whole Blood: Novel Biomarkers for Bortezomib Responses Obtained from a Prospective Multicenter Trial for Patients with Multiple Myeloma

Takashi Watanabe, Masato Mitsuhashi, [ ... ], Masahiro Kizaki

Different Associations of CD45 Isoforms with STAT3, PKC and ERK Regulate IL-6-Induced Proliferation in Myeloma

Xu Zheng, Allison S. Li, [ ... ], Huawei Zou

NOD/SCID-GAMMA Mice Are an Ideal Strain to Assess the Efficacy of Therapeutic Agents Used in the Treatment of Myeloma Bone Disease

Michelle A. Lawson, Julia M. Paton-Hough, [ ... ], Andrew D. Chantry

A Novel Phthalimide Derivative, TC11, Has Preclinical Effects on High-Risk Myeloma Cells and Osteoclasts

Maiko Matsushita, Yoshie Ozaki, [ ... ], Yutaka Hattori

Establishment of a Murine Graft-versus-Myeloma Model Using Allogeneic Stem Cell Transplantation

Marilène Binsfeld, Yves Beguin, [ ... ], Jo Caers

Advertisement

Create a weekly email alert for: Myeloma cells

You can change these options by clicking profile then "Alerts and Notifications"